EP Patent

EP3093035A1 — Injection device for delivery of a liquid medicament

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2016-11-16 · 10y expired

What this patent protects

The present invention relates to an injection device for dispensing of a liquid medicament, the device comprising: - an elongated housing (12) extending in an axial direction (z) to accommodate a cartridge (14), wherein the axial length of the interior of the housing (12) exceed…

USPTO Abstract

The present invention relates to an injection device for dispensing of a liquid medicament, the device comprising: - an elongated housing (12) extending in an axial direction (z) to accommodate a cartridge (14), wherein the axial length of the interior of the housing (12) exceeds the axial length of the cartridge (14) to axially displace the cartridge (14) inside the housing (12) between an undeployed proximal position (P) and a deployed distal position (D), - a drive member (50; 150; 250; 350) axially displaceable inside the housing (12) and being in sealed engagement (57) with a side wall (13) of the housing (12), - wherein the drive member (50; 150; 250; 350) has an abutment face (60; 160; 260; 360) to axially abut with a proximal end (17) of a barrel (15) of the cartridge (14) to displace the cartridge (14) from the undeployed position (P) towards the deployed position (D), - wherein the drive member (50; 150; 250; 350) has an outlet (51; 151; 251; 351) located distally from the sealed engagement (57) and further has an inlet (53; 153; 253; 353) located proximally from the sealed engagement (57), wherein the inlet (53; 153; 253; 353) and the outlet (51, 151; 251; 351) are in flow connection with each other via a flow path (68) extending through the drive member (50; 150; 250; 350) and wherein at least one flow restrictor (55; 155; 255; 355) is arranged across or in the flow path (68).

Drugs covered by this patent

Patent Metadata

Patent number
EP3093035A1
Jurisdiction
EP
Classification
Expires
2016-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.